Advocates and clinicians say that patients are still having trouble getting refills, even though the FDA has lifted REMS for ...

For 35 years, the FDA has placed onerous restrictions on the only drug it has ever approved for treatment-resistant ...

Cognitive behavioral therapy, periodic communication after suicide attempt, and pharmacologic treatments are important tools for veteran treatment.

(HealthDay News) — The U.S. Food and Drug Administration has removed one hurdle faced by patients with schizophrenia when filling prescriptions for the antipsychotic medication clozapine.

Patients will no longer need to provide blood test results before they can get clozapine prescriptions filled, according to ...

By Ellen Barry The Food and Drug Administration has taken a crucial step toward expanding access to the antipsychotic medication clozapine, the only drug approved for treatment-resistant ...

A third of people with schizophrenia have symptoms that will not sufficiently respond to two adequate trials of antipsychotic medications.1 For these people with treatment-resistant schizophrenia, ...

Clozapine, a medication approved by the FDA more than three decades ago, has been shown to be the most effective treatment for individuals with treatment-resistant schizophrenia. Yet, due to ...

FDA Makes Access to Clozapine Easier for Patients With Schizophrenia By Stephanie Brown HealthDay Reporter FRIDAY, Feb. 28, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has ...